This company has been marked as potentially delisted and may not be actively trading. Deciphera Pharmaceuticals (DCPH) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock DCPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period U.S. FDA Grants Full Approval of Deciphera's ROMVIMZAâ„¢ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)February 14, 2025 | businesswire.comU.S. Food and Drug Administration Accepts for Priority Review Deciphera’s New Drug Application for Vimseltinib for the Treatment of Patients with Tenosynovial Giant Cell ...August 16, 2024 | businesswire.comFisher Asset Management LLC Purchases Shares of 62,372 Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)June 23, 2024 | marketbeat.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Purchased by Goldman Sachs Group Inc.June 22, 2024 | marketbeat.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Sold by Parkman Healthcare Partners LLCJune 13, 2024 | marketbeat.comBraidwell LP Has $18.86 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)June 12, 2024 | marketbeat.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Bought by Nebula Research & Development LLCJune 11, 2024 | marketbeat.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 1-Year High at $25.59June 10, 2024 | marketbeat.comNew Leaf Venture Partners L.L.C. Sells 632,596 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)June 8, 2024 | marketbeat.com50,735 Shares in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Acquired by Campbell & CO Investment Adviser LLCJune 7, 2024 | marketbeat.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Bought by Armistice Capital LLCJune 5, 2024 | marketbeat.comDimensional Fund Advisors LP Raises Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)June 4, 2024 | marketbeat.comDeciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The LancetJune 3, 2024 | businesswire.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 52-Week High at $25.55May 31, 2024 | marketbeat.comBNP Paribas Financial Markets Boosts Stock Holdings in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)May 28, 2024 | marketbeat.comTrexquant Investment LP Takes $2.19 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)May 26, 2024 | marketbeat.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Average Recommendation of "Hold" from BrokeragesMay 24, 2024 | marketbeat.comDeciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expiresMay 22, 2024 | msn.comJump Financial LLC Takes $522,000 Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)May 22, 2024 | marketbeat.comPanagora Asset Management Inc. Acquires 144,097 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)May 19, 2024 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH), Atara Biotherapeutics (ATRA) and Nkarta (NKTX)May 16, 2024 | markets.businessinsider.comDeciphera Pharmaceuticals: Hold Rating Amid Acquisition and Concerns Over Qinlock SalesMay 14, 2024 | markets.businessinsider.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Sees Strong Trading VolumeMay 13, 2024 | marketbeat.comDCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024May 10, 2024 | investorplace.comFisher Asset Management LLC Acquires New Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)May 10, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNKMay 2, 2024 | stockhouse.comDECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPHMay 1, 2024 | businesswire.comBarclays Upgrades Deciphera Pharmaceuticals (DCPH)May 1, 2024 | msn.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Cut to Market Perform at Leerink PartnrsMay 1, 2024 | marketbeat.comJefferies Downgrades Deciphera Pharmaceuticals (DCPH)April 30, 2024 | msn.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Down 5.1% in AprilApril 30, 2024 | marketbeat.comDeep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)April 30, 2024 | markets.businessinsider.comJonesTrading Downgrades Deciphera Pharmaceuticals (DCPH)April 30, 2024 | msn.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Sees Large Volume IncreaseApril 30, 2024 | marketbeat.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Earns "Neutral" Rating from GuggenheimApril 30, 2024 | marketbeat.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Rating Increased to Equal Weight at BarclaysApril 30, 2024 | marketbeat.comONO Enters into a Definitive Agreement to Acquire Deciphera PharmaceuticalsApril 30, 2024 | finance.yahoo.comJapan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansionApril 30, 2024 | reuters.comINVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPHApril 29, 2024 | prnewswire.comDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesApril 29, 2024 | marketbeat.comDeciphera to be acquired by Japanese drug firm for $2.4 billionApril 29, 2024 | msn.comUpdate: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion DealApril 29, 2024 | finance.yahoo.comDeciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%April 29, 2024 | finance.yahoo.comJefferies Financial Group Reaffirms Hold Rating for Deciphera Pharmaceuticals (NASDAQ:DCPH)April 29, 2024 | marketbeat.comWhy Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?April 29, 2024 | investorplace.comShareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.April 29, 2024 | prnewswire.comDeciphera Pharmaceuticals (NASDAQ:DCPH) Reaches New 52-Week High at $25.03April 29, 2024 | marketbeat.comDeciphera Pharmaceuticals Is Being Acquired and the Stock Soars 71%April 29, 2024 | barrons.comDCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to ShareholdersApril 29, 2024 | businesswire.comJapan's ONO Pharmaceutical to buy Deciphera for $2.4 billionApril 29, 2024 | reuters.com Get Deciphera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DCPH Media Mentions By Week DCPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DCPH News Sentiment▼0.000.71▲Average Medical News Sentiment DCPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DCPH Articles This Week▼00▲DCPH Articles Average Week Get the Latest News and Ratings for DCPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Deciphera Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ELAN News Today ROIV News Today GRFS News Today RVMD News Today RYTM News Today LEGN News Today ABVX News Today RNA News Today AXSM News Today NUVL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DCPH) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Deciphera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
